Elderly nursing home residents who receive antipsychotic drugs almost always receive them for off-label conditions, including conditions flagged in a black-box warning on the medications' labeling, according to a report from the Department of Health and Human Services Office of Inspector General. Anti...
CONCLUSION: The FDA advisory was associated with decreases in the use of atypical antipsychotics, especially among elderly patients with dementia.doi:10.1001/archinternmed.2009.456DorseyE. RayArch Intern MedArchives of Internal MedicineDorsey ER, Rabbani A, Gallagher SA, Conti RM, Alexander GC: ...
In April 2005, the Food and Drug Administration (FDA) issued a black box warning (BBW) regarding the risks of using atypical antipsychotics (AAPs) for behavioral disorders in elderly patients with dementia. The objective of the present study was to investigate the impact of the BBW on the ...
For instance, antipsychotics like Risperdal have a black box warning for increased death in older patients. A 2010 study published in Archives of Internal Medicine (now JAMA Internal Medicine) by Dr. E. Ray Dorsey and colleagues showed that antipsychotic use fell after the FDA added a black box...
In April 2005, the Food and Drug Administration (FDA) issued a black box warning (BBW) regarding the risks of using atypical antipsychotics (AAPs) for behavioral disorders in elderly patients with dementia. The objective of the present study was to investigate the impact of the BBW on the ...
This analysis explores trends and patterns of "off-label" use of antipsychotics in the elderly. Methods Longitudinal analysis of a large nationally representative administrative claims database (2005-201 0). The sample includes Medicare, Medicaid and commercially insured patients aged 65+ enrolled 11-...